Literature DB >> 10659883

Postmenopausal estrogens--opposed, unopposed, or none of the above.

W C Willett, G Colditz, M Stampfer.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10659883     DOI: 10.1001/jama.283.4.534

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Data on effect of HRT on breast cancer conflict with other data.

Authors:  R Vidya; J M Dixon
Journal:  BMJ       Date:  2000-07-15

2.  [Should the menopause be treated?].

Authors:  E Bailón
Journal:  Aten Primaria       Date:  2004-03-15       Impact factor: 1.137

3.  [Attitude to a post-menopausal woman who consults due to flushes and dyspareunia].

Authors:  D Sánchez-Mariscal; E Bailón-Muñoz
Journal:  Aten Primaria       Date:  2006-02-28       Impact factor: 1.137

Review 4.  Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.

Authors:  Carlo Campagnoli; Françoise Clavel-Chapelon; Rudolf Kaaks; Clementina Peris; Franco Berrino
Journal:  J Steroid Biochem Mol Biol       Date:  2005-07       Impact factor: 4.292

5.  The effects of hormone therapy decision support for women with mobility impairments.

Authors:  Heather Becker; Alexa K Stuifbergen; Sharon L Dormire
Journal:  Health Care Women Int       Date:  2009-09

6.  Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort.

Authors:  Richard L Nelson; Mary Turyk; Jane Kim; Victoria Persky
Journal:  BMC Cancer       Date:  2002-09-12       Impact factor: 4.430

7.  Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin.

Authors:  Graham A Colditz
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.